137 research outputs found
Predictive factors for functional improvement after intravitreal bevacizumab therapy for macular edema due to branch retinal vein occlusion
Venous retinal flow reperfusion mechanisms following radial optic neurotomy with adjunctive intraocular triamcinolone in central retinal vein occlusion
Branch Retinal Vein Occlusion: Pathogenesis, Visual Prognosis, and Treatment Modalities
In branch retinal vein occlusion (BRVO), abnormal arteriovenous crossing with vein compression, degenerative changes of the vessel wall and abnormal hematological factors constitute the primary mechanism of vessel occlusion. In general, BRVO has a good prognosis: 50–60% of eyes are reported to have a final visual acuity (VA) of 20/40 or better even without treatment. One important prognostic factor for final VA appears to be the initial VA. Grid laser photocoagulation is an established treatment for macular edema in a particular group of patients with BRVO, while promising results for this condition are shown by intravitreal application of steroids or new vascular endothelial growth factor inhibitors. Vitrectomy with or without arteriovenous sheathotomy combined with removal of the internal limiting membrane may improve vision in eyes with macular edema which are unresponsive to or ineligible for laser treatment
Neovascularized Best Disease in Child: Contribution of Optical Coherence Tomography Angiography
Influence of Pars Plana Vitrectomy on Macular Sensitivity and Morphology in Patients with Branch Retinal Vein Occlusion and Serous Retinal Detachment
Résultats de la translocation maculaire limitée dans la néovascularisation choroïdienne rétrofovéale de la dégénérescence maculaire liée à l’âge
Combined central retinal vein and cilioretinal artery occlusion related to acute intra-ocular pressure rise of previously unknown pigment dispersion syndrome
- …